Asia
The United States continues to headline an annual list of influential science researchers, but that lead is dipping as other global scientists gain recognition from their peers for the work they are conducting.
George Chen left AstraZeneca after seven years to pursue his own line of oncology and immunology R&D.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 10, 2020.
It was relatively quiet in terms of COVID-19-related clinical trials, but there was still quite a bit of news for trials involving other indications. Here’s a look.
When it comes to a novel virus like SARS-CoV2, a certain amount of “rolling with the punches” is required, and governments and global organizations like the World Health Organization are beginning to dismiss certain treatments and devote themselves wholeheartedly to others.
Biogen and Tokyo-based development partner Eisai are embroiled in controversy surrounding their investigational Alzheimer’s drug, aducanumab.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Find out which biopharma companies are raking in the cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 3, 2020.
It was a particularly busy week for announcements about clinical trials, both related to COVID-19 and everything else. Here’s a look.
PRESS RELEASES